Mesothelioma Cancer Resources Blog

On July 2nd, asbestos-related disease victims, their family members and advocates will hold a ceremony to release doves in Manchester, England to mark Action Mesothelioma Day.  Organizers want to remember those who have died from mesothelioma and raise awareness of the dangers of asbestos for future generations. Mesothelioma is a rare form of cancer primarily caused by …

Oxford BioMedica and a team of cancer immunologists from Cardiff University in Great Britain are collaborating to evaluate TroVax in a Phase I/II study for mesothelioma.  The study aims to examine the effect of TroVax in combination with first-line chemotherapy agents Alimta and cisplatin as a treatment against malignant mesothelioma. Mesothelioma is a rare, aggressive …

One of the tragic facts of mesothelioma is that once diagnosed the average survival time is from 4-18 months.  While it can be treated with varying degrees of success through the use of surgical procedures, chemotherapy and radiation, there is still no known cure. When a mesothelioma patient no longer responds to a prescribed treatment …